ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,782Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 93

$937K Total Retail Price of All Prescriptions

Rank: 3 out of 93

518 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 518 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

26% of this provider’s 518 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 11,652 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
HYDROCODONE-ACETAMINOPHEN 797 486 S3 1 9
TRAMADOL HCL 523 380 2 15
LISINOPRIL 469 342 3 3
LEVOTHYROXINE SODIUM 451 318 4 5
AMLODIPINE BESYLATE 432 332 5 6
SIMVASTATIN 415 285 6 2
DIOVAN HCT 396 277 7 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 366 241 8 28
METFORMIN HCL 352 210 9 7
HYDROCHLOROTHIAZIDE 317 245 10 10
FUROSEMIDE 314 242 11 4
RANITIDINE HCL 312 236 12 21
METOPROLOL TARTRATE 302 250 13 11
OMEPRAZOLE 244 180 14 8
GABAPENTIN 241 149 15 17
ATORVASTATIN CALCIUM 219 159 16 18
POTASSIUM CHLORIDE 218 150 17 13
WARFARIN SODIUM 192 164 18 12
DIOVAN 192 127 18 35
CLOPIDOGREL 171 122 20 27
NEXIUM 164 106 21 33
CRESTOR 164 60 21 31
METOPROLOL SUCCINATE 160 124 23 14
RISPERIDONE 153 47 24 54
TAMSULOSIN HCL 149 103 25 24
SINGULAIR 147 96 26 71
ZOLPIDEM TARTRATE 146 95 27 40
SPIRONOLACTONE 144 82 28 67
CARVEDILOL 143 87 29 23
AVODART 139 110 30 157
ATENOLOL 134 90 31 16
PLAVIX 124 93 32 44
AZITHROMYCIN 119 95 33 51
HYDRALAZINE HCL 119 70 33 73
LOSARTAN-HYDROCHLOROTHIAZIDE 115 78 35 75
PANTOPRAZOLE SODIUM 111 81 36 36
INSULIN SYRINGE 110 72 37 88
CITALOPRAM HBR 109 80 38 45
SPIRIVA 109 102 38 69
ZETIA 108 70 40 92
SYMBICORT 105 94 41 145
DONEPEZIL HCL 103 97 42 25
LANTUS 101 82 43 68
NAMENDA 98 98 44 55
PRAVASTATIN SODIUM 96 69 45 20
ALLOPURINOL 95 47 46 29
CYCLOBENZAPRINE HCL 92 38 R 47 71
GLIPIZIDE XL 92 42 47 81
COMBIVENT 91 72 49 123
PREDNISONE 90 79 50 49
CLONIDINE HCL 85 46 51 50
DIGOXIN 83 71 52 48
PROAIR HFA 83 44 52 37
METHYLPREDNISOLONE 82 63 54 144
POLYETHYLENE GLYCOL 3350 80 62 55 63
VENTOLIN HFA 79 59 56 83
TIZANIDINE HCL 79 64 56 111
LOVAZA 77 42 58 58
GLIPIZIDE 75 60 59 41
LANTUS SOLOSTAR 74 29 60 96
VALSARTAN-HYDROCHLOROTHIAZIDE 73 53 61 210
AMLODIPINE BESYLATE-BENAZEPRIL 73 65 61 53
CYMBALTA 71 24 63 84
LOSARTAN POTASSIUM 69 68 64 26
LYRICA 68 49 65 141
NAPROXEN 66 46 66 57
COREG CR 66 49 66 166
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 49 68 97
LANSOPRAZOLE 63 59 69 118
ISOSORBIDE MONONITRATE ER 63 26 69 62
LEVETIRACETAM 63 63 69 125
LIPITOR 60 44 72 158
AMITRIPTYLINE HCL 60 50 R 72 61
BYSTOLIC 59 42 74 116
GLIPIZIDE ER 59 59 74 56
ESCITALOPRAM OXALATE 58 44 76 116
NIASPAN 58 30 76 89
VERAPAMIL ER 58 46 76 98
DOXAZOSIN MESYLATE 57 41 79 70
TRILIPIX 55 38 80 234
NIFEDIPINE ER 54 26 81 46
ADVAIR DISKUS 52 52 82 59
NOVOLOG 52 28 82 177
BENICAR HCT 52 12 82 180
MONTELUKAST SODIUM 51 30 85 151
DILTIAZEM 24HR ER 50 38 86 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.